TRANSGENE BIOTEK LTD. - Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Financial Year Ended March 31, 2023.

a) Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2023. b) Report of the Auditors on the Audited Financial Results, both for Standalone and Consolidated financial statements for the financial year ended March 31, 2023. c) Declaration pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Consolidated and Standalone Financial Statements for the Financial Year ended March 31, 2023.